These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 15907526)

  • 41. Comparison of argatroban and fondaparinux for the management of patients with isolated heparin-induced thrombocytopenia.
    Al-Eidan FAS; Alrawkan S; Alshammary H; Crowther MA
    Ann Hematol; 2018 Nov; 97(11):2055-2059. PubMed ID: 30003318
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Argatroban therapy for heparin-induced thrombocytopenia in ICU patients with multiple organ dysfunction syndrome: a retrospective study.
    Saugel B; Phillip V; Moessmer G; Schmid RM; Huber W
    Crit Care; 2010; 14(3):R90. PubMed ID: 20487559
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy and safety of argatroban and bivalirudine in patients with suspected heparin-induced thrombocytopenia.
    Vo QA; Lin JK; Tong LM
    Ann Pharmacother; 2015 Feb; 49(2):178-84. PubMed ID: 25515865
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Treatment options for heparin-induced thrombocytopenia.
    Greinacher A
    Am J Health Syst Pharm; 2003 Oct; 60 Suppl 5():S12-8. PubMed ID: 14593978
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of body mass index on Argatroban therapy during percutaneous coronary intervention.
    Hursting MJ; Jang IK
    J Thromb Thrombolysis; 2008 Jun; 25(3):273-9. PubMed ID: 17530465
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intravenous warfarin and heparin-induced thrombocytopenia: making the diagnosis, management, modern monitoring, and multidisciplinary care.
    Burger CF; Schlesinger JJ
    Ann Pharmacother; 2014 Feb; 48(2):286-91. PubMed ID: 24259642
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Use of argatroban during percutaneous coronary interventions in patients with heparin-induced thrombocytopenia.
    Matthai WH
    Semin Thromb Hemost; 1999; 25 Suppl 1():57-60. PubMed ID: 10357153
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reducing harm associated with anticoagulation: practical considerations of argatroban therapy in heparin-induced thrombocytopenia.
    Hursting MJ; Soffer J
    Drug Saf; 2009; 32(3):203-18. PubMed ID: 19338378
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Argatroban dose reductions for suspected heparin-induced thrombocytopenia complicated by child-pugh class C liver disease.
    Yarbrough PM; Varedi A; Walker A; Rondina MT
    Ann Pharmacother; 2012 Nov; 46(11):e30. PubMed ID: 23073302
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Recognition of heparin-induced thrombocytopenia and initiation of argatroban therapy after cardiothoracic surgery in the intensive care unit.
    Demma LJ; Paciullo CA; Levy JH
    J Thorac Cardiovasc Surg; 2012 May; 143(5):1213-8. PubMed ID: 22329977
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Argatroban versus heparin in patients without heparin-induced thrombocytopenia during venovenous extracorporeal membrane oxygenation: a propensity-score matched study.
    Fisser C; Winkler M; Malfertheiner MV; Philipp A; Foltan M; Lunz D; Zeman F; Maier LS; Lubnow M; Müller T
    Crit Care; 2021 Apr; 25(1):160. PubMed ID: 33910609
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prolonged anticoagulation after discontinuation of argatroban and warfarin therapy in an obese patient with heparin-induced thrombocytopenia.
    Shapiro NL; Durr EA; Krueger CD
    Pharmacotherapy; 2006 Dec; 26(12):1806-10. PubMed ID: 17125442
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Argatroban use in heparin-induced thrombocytopenia.
    Boggio LN; Oza VM
    Expert Opin Pharmacother; 2008 Aug; 9(11):1963-7. PubMed ID: 18627333
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Use of argatroban as a procedural and bridging anticoagulant in a patient undergoing carotid endarterectomy with concomitant atrial fibrillation.
    Nanda MM; Kauflin MJ; Jain PG; Yannetta JC
    Ann Pharmacother; 2011 Mar; 45(3):e16. PubMed ID: 21386022
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Argatroban dosing of patients with heparin-induced thrombocytopenia and an elevated aPTT due to antiphospholipid antibody syndrome.
    Pendleton R; Wheeler MM; Rodgers GM
    Ann Pharmacother; 2006 May; 40(5):972-6. PubMed ID: 16569813
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Argatroban anticoagulation in critically ill patients.
    Beiderlinden M; Treschan TA; Görlinger K; Peters J
    Ann Pharmacother; 2007 May; 41(5):749-54. PubMed ID: 17440009
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A comparison of direct thrombin inhibitors in the treatment of Heparin-Induced Thrombocytopenia: a single institution experience.
    Curzio KM; Cheng-Lai A; Kheyfets V; Sinnet M; Billett HH
    J Thromb Thrombolysis; 2009 Aug; 28(2):117-23. PubMed ID: 18827975
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Heparin-induced thrombocytopenia in patients administered heparin solely for hemodialysis.
    Murray PT; Hursting MJ
    Ren Fail; 2006; 28(7):537-9. PubMed ID: 17050234
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy and safety of argatroban in patients with heparin induced thrombocytopenia undergoing endovascular intervention for peripheral arterial disease.
    Baron SJ; Yeh RW; Cruz-Gonzalez I; Healy JL; Pomerantsev E; Garasic J; Drachman D; Rosenfield K; Jang IK
    Catheter Cardiovasc Interv; 2008 Jul; 72(1):116-20. PubMed ID: 18546237
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prolonged elevation of plasma argatroban in a cardiac transplant patient with a suspected history of heparin-induced thrombocytopenia with thrombosis.
    Genzen JR; Fareed J; Hoppensteadt D; Kurup V; Barash P; Coady M; Wu YY
    Transfusion; 2010 Apr; 50(4):801-7. PubMed ID: 20003049
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.